Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analysesM. Jagasia, E. Beohou,S. van der Werf,D. Niederwieser, P. Dreger,E. Meijer,P. Chevallier,H. Sengeloev,D. Blaise,E. Petersen,J. J. Cornelissen,G. Ehninger,J. Gribben,D. Caballero, Y. Beguin, M. Hallek,P. Jindra,R. Fanin, J. Delage,J. Maertens,T. Gedde-Dahl, S. Montoto,N. Kroger, H. Greinix,R. DuarteBONE MARROW TRANSPLANTATION（2017）引用 0|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
